Severe vemurafenib‐induced photosensitivity in a 6‐year‐old boy

Vemurafenib, a selective BRAF kinase inhibitor, has been found to induce several cutaneous adverse effects, ranging from a keratosis pilaris‐like reaction to squamous cell carcinoma. While photosensitivity has been well described as one of these manifestations, we report a case of a 6‐year‐old boy o...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric dermatology 2019-01, Vol.36 (1), p.e62-e63
Main Authors: Jew, Olivia S., Provini, Lauren E., Treat, James R.
Format: Article
Language:English
Subjects:
Case reports
Chemotherapy
drug reaction
Enzyme inhibitors
Inhibitor drugs
Keratosis
neoplasms—malignant
Pediatrics
Photosensitivity
Side effects
Skin cancer
Squamous cell carcinoma
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3530-20b80f65bdf61430d996e4896cec7c9773aba1b04967512e8b1db6ddef25fbef3
cites cdi_FETCH-LOGICAL-c3530-20b80f65bdf61430d996e4896cec7c9773aba1b04967512e8b1db6ddef25fbef3
container_end_page e63
container_issue 1
container_start_page e62
container_title Pediatric dermatology
container_volume 36
creator Jew, Olivia S.
Provini, Lauren E.
Treat, James R.
description Vemurafenib, a selective BRAF kinase inhibitor, has been found to induce several cutaneous adverse effects, ranging from a keratosis pilaris‐like reaction to squamous cell carcinoma. While photosensitivity has been well described as one of these manifestations, we report a case of a 6‐year‐old boy on vemurafenib who developed a severe blistering sunburn after only two 30‐minute episodes of sun exposure. A brief review of other common cutaneous adverse effects of vemurafenib is also provided.
doi_str_mv 10.1111/pde.13720
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2138043022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2138043022</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-20b80f65bdf61430d996e4896cec7c9773aba1b04967512e8b1db6ddef25fbef3</originalsourceid><addsrcrecordid>eNp10L9OwzAQBnALgWgpDLwAisQCQ9qzndjJiEr5I1UCCZijOL4IV2lS7KYoG4_AM_IkGFIYkLjllp8-3X2EHFMYUz-TlcYx5ZLBDhnSmMUhjSTskiFILsIEIjEgB84tACARgu6TAYdIRomMh2T2gBu0GGxw2dq8xNqoj7d3U-u2QB2snpt147B2Zm02Zt0Fpg7yQHjRYW79aiodqKY7JHtlXjk82u4RebqaPU5vwvnd9e30Yh4WPOYQMlAJlCJWuhQ04qDTVGCUpKLAQhaplDxXOVUQpULGlGGiqFZCayxZXCos-Yic9bkr27y06NbZ0rgCqyqvsWldxij373JgzNPTP3TRtLb213klgXNGIfbqvFeFbZyzWGYra5a57TIK2Ve3me82--7W25NtYquWqH_lT5keTHrwairs_k_K7i9nfeQnPruE5A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2170332105</pqid></control><display><type>article</type><title>Severe vemurafenib‐induced photosensitivity in a 6‐year‐old boy</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Jew, Olivia S. ; Provini, Lauren E. ; Treat, James R.</creator><creatorcontrib>Jew, Olivia S. ; Provini, Lauren E. ; Treat, James R.</creatorcontrib><description>Vemurafenib, a selective BRAF kinase inhibitor, has been found to induce several cutaneous adverse effects, ranging from a keratosis pilaris‐like reaction to squamous cell carcinoma. While photosensitivity has been well described as one of these manifestations, we report a case of a 6‐year‐old boy on vemurafenib who developed a severe blistering sunburn after only two 30‐minute episodes of sun exposure. A brief review of other common cutaneous adverse effects of vemurafenib is also provided.</description><identifier>ISSN: 0736-8046</identifier><identifier>EISSN: 1525-1470</identifier><identifier>DOI: 10.1111/pde.13720</identifier><identifier>PMID: 30474875</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Case reports ; Chemotherapy ; drug reaction ; Enzyme inhibitors ; Inhibitor drugs ; Keratosis ; neoplasms—malignant ; Pediatrics ; Photosensitivity ; Side effects ; Skin cancer ; Squamous cell carcinoma</subject><ispartof>Pediatric dermatology, 2019-01, Vol.36 (1), p.e62-e63</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>Copyright © 2019 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-20b80f65bdf61430d996e4896cec7c9773aba1b04967512e8b1db6ddef25fbef3</citedby><cites>FETCH-LOGICAL-c3530-20b80f65bdf61430d996e4896cec7c9773aba1b04967512e8b1db6ddef25fbef3</cites><orcidid>0000-0002-6625-2134 ; 0000-0001-8061-3269</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30474875$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jew, Olivia S.</creatorcontrib><creatorcontrib>Provini, Lauren E.</creatorcontrib><creatorcontrib>Treat, James R.</creatorcontrib><title>Severe vemurafenib‐induced photosensitivity in a 6‐year‐old boy</title><title>Pediatric dermatology</title><addtitle>Pediatr Dermatol</addtitle><description>Vemurafenib, a selective BRAF kinase inhibitor, has been found to induce several cutaneous adverse effects, ranging from a keratosis pilaris‐like reaction to squamous cell carcinoma. While photosensitivity has been well described as one of these manifestations, we report a case of a 6‐year‐old boy on vemurafenib who developed a severe blistering sunburn after only two 30‐minute episodes of sun exposure. A brief review of other common cutaneous adverse effects of vemurafenib is also provided.</description><subject>Case reports</subject><subject>Chemotherapy</subject><subject>drug reaction</subject><subject>Enzyme inhibitors</subject><subject>Inhibitor drugs</subject><subject>Keratosis</subject><subject>neoplasms—malignant</subject><subject>Pediatrics</subject><subject>Photosensitivity</subject><subject>Side effects</subject><subject>Skin cancer</subject><subject>Squamous cell carcinoma</subject><issn>0736-8046</issn><issn>1525-1470</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp10L9OwzAQBnALgWgpDLwAisQCQ9qzndjJiEr5I1UCCZijOL4IV2lS7KYoG4_AM_IkGFIYkLjllp8-3X2EHFMYUz-TlcYx5ZLBDhnSmMUhjSTskiFILsIEIjEgB84tACARgu6TAYdIRomMh2T2gBu0GGxw2dq8xNqoj7d3U-u2QB2snpt147B2Zm02Zt0Fpg7yQHjRYW79aiodqKY7JHtlXjk82u4RebqaPU5vwvnd9e30Yh4WPOYQMlAJlCJWuhQ04qDTVGCUpKLAQhaplDxXOVUQpULGlGGiqFZCayxZXCos-Yic9bkr27y06NbZ0rgCqyqvsWldxij373JgzNPTP3TRtLb213klgXNGIfbqvFeFbZyzWGYra5a57TIK2Ve3me82--7W25NtYquWqH_lT5keTHrwairs_k_K7i9nfeQnPruE5A</recordid><startdate>201901</startdate><enddate>201901</enddate><creator>Jew, Olivia S.</creator><creator>Provini, Lauren E.</creator><creator>Treat, James R.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6625-2134</orcidid><orcidid>https://orcid.org/0000-0001-8061-3269</orcidid></search><sort><creationdate>201901</creationdate><title>Severe vemurafenib‐induced photosensitivity in a 6‐year‐old boy</title><author>Jew, Olivia S. ; Provini, Lauren E. ; Treat, James R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-20b80f65bdf61430d996e4896cec7c9773aba1b04967512e8b1db6ddef25fbef3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Case reports</topic><topic>Chemotherapy</topic><topic>drug reaction</topic><topic>Enzyme inhibitors</topic><topic>Inhibitor drugs</topic><topic>Keratosis</topic><topic>neoplasms—malignant</topic><topic>Pediatrics</topic><topic>Photosensitivity</topic><topic>Side effects</topic><topic>Skin cancer</topic><topic>Squamous cell carcinoma</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jew, Olivia S.</creatorcontrib><creatorcontrib>Provini, Lauren E.</creatorcontrib><creatorcontrib>Treat, James R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jew, Olivia S.</au><au>Provini, Lauren E.</au><au>Treat, James R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Severe vemurafenib‐induced photosensitivity in a 6‐year‐old boy</atitle><jtitle>Pediatric dermatology</jtitle><addtitle>Pediatr Dermatol</addtitle><date>2019-01</date><risdate>2019</risdate><volume>36</volume><issue>1</issue><spage>e62</spage><epage>e63</epage><pages>e62-e63</pages><issn>0736-8046</issn><eissn>1525-1470</eissn><abstract>Vemurafenib, a selective BRAF kinase inhibitor, has been found to induce several cutaneous adverse effects, ranging from a keratosis pilaris‐like reaction to squamous cell carcinoma. While photosensitivity has been well described as one of these manifestations, we report a case of a 6‐year‐old boy on vemurafenib who developed a severe blistering sunburn after only two 30‐minute episodes of sun exposure. A brief review of other common cutaneous adverse effects of vemurafenib is also provided.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30474875</pmid><doi>10.1111/pde.13720</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-6625-2134</orcidid><orcidid>https://orcid.org/0000-0001-8061-3269</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0736-8046
ispartof Pediatric dermatology, 2019-01, Vol.36 (1), p.e62-e63
issn 0736-8046
1525-1470
language eng
recordid cdi_proquest_miscellaneous_2138043022
source Wiley-Blackwell Read & Publish Collection
subjects Case reports
Chemotherapy
drug reaction
Enzyme inhibitors
Inhibitor drugs
Keratosis
neoplasms—malignant
Pediatrics
Photosensitivity
Side effects
Skin cancer
Squamous cell carcinoma
title Severe vemurafenib‐induced photosensitivity in a 6‐year‐old boy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T10%3A37%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Severe%20vemurafenib%E2%80%90induced%20photosensitivity%20in%20a%206%E2%80%90year%E2%80%90old%20boy&rft.jtitle=Pediatric%20dermatology&rft.au=Jew,%20Olivia%20S.&rft.date=2019-01&rft.volume=36&rft.issue=1&rft.spage=e62&rft.epage=e63&rft.pages=e62-e63&rft.issn=0736-8046&rft.eissn=1525-1470&rft_id=info:doi/10.1111/pde.13720&rft_dat=%3Cproquest_cross%3E2138043022%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3530-20b80f65bdf61430d996e4896cec7c9773aba1b04967512e8b1db6ddef25fbef3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2170332105&rft_id=info:pmid/30474875&rfr_iscdi=true